Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Haupt Pharma Wuelfing GmbH
EIR
•Haupt Pharma Wuelfing GmbH•March 17, 2017

Haupt Pharma Wuelfing GmbH – FDA EIR, Mar 17, 2017

Record Details

An FDA inspection of Haupt Pharma Wulfing GmbH in Gronau, Germany, was conducted from March 9 to March 17, 2017. The inspection, guided by Compliance Program 7371.001 for Animal Drug Manufacturing and referencing programs for general and sterile drug manufacturing, assessed the facility's adherence to current Good Manufacturing Practices (21 CFR 210/211) for products distributed in the United States. The current inspection verified the correction of four deficiencies from a 2015 inspection, which included issues with written production procedures, batch record completeness, facility maintenance, and equipment upkeep. While no formal FDA Form 483 was issued during the 2017 inspection, two verbal comments were raised. These concerned the lack of documented explanations for a 2.5-hour gap in HPLC chromatograms for an assay validation batch and the filling of bulk finished product prior to obtaining certain in-process control results. Haupt Pharma Wulfing GmbH's management committed to immediate corrective actions for these verbal observations. The facility is a contract manufacturer of solid dosage forms and sterile injectable products, though at the time of inspection, only tablets were approved and shipped to the US.

Company
Haupt Pharma Wuelfing GmbH
Inspection date
March 17, 2017
Product type
drugs
Office
Center for Devices and Radiological Health
People
  • Fabian Wendel (company_representative)
  • Susanne Dommasch (company_representative)
  • Miriam Rothenburger (recipient)
  • Heiko Baumann (company_representative)
  • Henrik Hoffmann (company_representative)
View Company Profile

ID · 637c3f8e-a473-4c13-95a0-76545a222f67

Violation Codes4
FD&C Act 501(a)(2)(B)21 CFR 21121 CFR 21021 CFR 820.50

Full citation text and observation details available on the Dashboard.

Other documents for Haupt Pharma Wuelfing GmbH
  • EIR - 2018-12-07December 7, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Haupt Pharma Wuelfing GmbH
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.